Tesamorelin – 10mg
$100.00
Tesamorelin (10mg) is a potent synthetic analog of Growth Hormone-Releasing Hormone (GHRH), specifically engineered to investigate the reduction of visceral adipose tissue and the stimulation of endogenous growth hormone.With a modified sequence that provides enhanced stability and resistance to enzymatic degradation, Tesamorelin is a premier tool for metabolic and endocrine research. Each vial is vacuum-sealed and guaranteed at 99% purity, providing the chemical precision required for high-stakes laboratory investigations.
Out of stock
Description
Overview of Tesamorelin
Tesamorelin (trans-3-hexenoyl-GHRH) is a stabilized synthetic peptide containing 44 amino acids. It mimics the action of endogenous GHRH by binding to and activating GHRH receptors in the anterior pituitary gland. The primary differentiator for Tesamorelin is its specialized N-terminal modification (a trans-3-hexenoyl group), which significantly increases its half-life compared to natural GHRH. In research, it is most notably studied for its lipolytic effects, particularly in the reduction of visceral fat, and its potential impact on cognitive function.
Primary Research Applications
This 10mg formulation is a cornerstone of metabolic and neuroendocrine research, utilized to explore:
-
Visceral Adipose Tissue (VAT) Reduction: Investigating the mechanisms by which GHRH analogs specifically target and reduce deep abdominal fat without affecting subcutaneous fat layers.
-
Growth Hormone Pulsatility: Analyzing the peptide’s ability to stimulate a natural, pulsatile release of growth hormone, thereby maintaining the body’s feedback loops.
-
Cognitive and Neurological Studies: Researching the potential of Tesamorelin to improve executive function and memory in models of mild cognitive impairment by increasing IGF-1 levels in the brain.
-
Lipid Profile Modulation: Studying the downstream effects of GHRH activation on triglyceride levels and overall lipid metabolism.
